ZimVie Inc Ordinary Shares ZIMV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
ZimVie Reports Second Quarter 2024 Financial Results
-
ZimVie Announces the Release of RealGUIDE® 5.4 Software Update
-
ZimVie Shares Rise on FDA's Clearance of Prosthesis Portfolio
-
ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components
-
ZimVie to Report Second Quarter Financial Results on August 1, 2024
Trading Information
- Previous Close Price
- $15.59
- Day Range
- $15.63–15.96
- 52-Week Range
- $6.52–22.40
- Bid/Ask
- $6.30 / $16.38
- Market Cap
- $434.53 Mil
- Volume/Avg
- 140,850 / 358,547
Key Statistics
- Price/Earnings (Normalized)
- 45.25
- Price/Sales
- 0.97
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,600
- Website
- https://www.zimvie.com
Comparables
Valuation
|
Metric
|
ZIMV
|
SIBN
|
603301
|
|---|---|---|---|
Price/Earnings (Normalized) | 45.25 | — | 22.34 |
Price/Book Value | 1.10 | 3.37 | 1.09 |
Price/Sales | 0.97 | 3.62 | 1.54 |
Price/Cash Flow | 48.41 | — | 9.31 |
Price/Earnings
ZIMV
SIBN
603301
Financial Strength
|
Metric
|
ZIMV
|
SIBN
|
603301
|
|---|---|---|---|
Quick Ratio | 1.06 | 7.99 | 1.57 |
Current Ratio | 1.94 | 9.17 | 2.24 |
Interest Coverage | 0.07 | −12.97 | 5.28 |
Quick Ratio
ZIMV
SIBN
603301
Profitability
|
Metric
|
ZIMV
|
SIBN
|
603301
|
|---|---|---|---|
Return on Assets (Normalized) | 0.60% | −6.03% | 1.65% |
Return on Equity (Normalized) | 1.42% | −8.10% | 2.34% |
Return on Invested Capital (Normalized) | 1.51% | −8.97% | 1.91% |
Return on Assets
ZIMV
SIBN
603301
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Jmmkmlrr | Bxcjr | $195.6 Bil | |||
| Stryker Corp
SYK
| Yvznmtzb | Lbj | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Fdbwcqgv | Ptswzy | $122.7 Bil | |||
| Medtronic PLC
MDT
| Cpczscj | Jbwns | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Vyvlnhnqb | Vdrly | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Wqjhd | Pnpf | $30.7 Bil | |||
| DexCom Inc
DXCM
| Pfkwzkgf | Ctv | $27.0 Bil | |||
| Steris PLC
STE
| Rjhwwqg | Dqnmpv | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Txnxzqngm | Rszx | $22.0 Bil | |||
| Insulet Corp
PODD
| Twwrpdvcc | Jyzbmd | $16.3 Bil |
United States